{"name":"Bilastine","slug":"bilastine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Ilaxten","Bilastina","Bilastinum","R06ax29","Bilaxten","Gtpl11579","Bs-15792","Bilasten","Bilatex","Bilastine?"],"brands":[],"scraped":true,"has_structure":true,"cid":185460,"classes":[],"families":[{"name":"phenethylpiperidine","href":"/substituted/phenethylpiperidine"}],"physical":[{"label":"Molecular mass","value":"463.60 g/mol","copyable":false},{"label":"Predicted LogP","value":"2.3","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>28</sub>H<sub>37</sub>N<sub>3</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"2-[4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]ethyl]phenyl]-2-methylpropanoic acid","copyable":true},{"label":"SMILES","value":"CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O","copyable":true},{"label":"InChI","value":"InChI=1S/C28H37N3O3/c1-4-34-20-19-31-25-8-6-5-7-24(25)29-26(31)22-14-17-30(18-15-22)16-13-21-9-11-23(12-10-21)28(2,3)27(32)33/h5-12,22H,4,13-20H2,1-3H3,(H,32,33)","copyable":true},{"label":"InChIKey","value":"ACCMWZWAEFYUGZ-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"202189-78-4","copyable":true},{"label":"UNII","value":"PA1123N395","copyable":true},{"label":"PubChem CID","value":"185460","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"1 hour (Allertine)","copyable":false},{"label":"Elimination half-life","value":"14.5 hours","copyable":false},{"label":"Duration of action","value":"24 hours (Allertine)","copyable":false},{"label":"Metabolism","value":"Not significantly metabolised","copyable":false},{"label":"Excretion","value":"95% in urine and faeces","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[],"dosing":null,"salts":[],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"R","description":"Respiratory system"},{"code":"R06","description":"Antihistamines for systemic use"},{"code":"R06A","description":"Antihistamines for systemic use"},{"code":"R06AX","description":"Other antihistamines for systemic use"},{"code":"R06AX29","description":""},{"code":"R06AX29","description":"Bilastine"},{"code":"S","description":"Sensory organs"},{"code":"S01","description":"Ophthalmologicals"},{"code":"S01G","description":"Decongestants and antiallergics"},{"code":"S01GX","description":"Other antiallergics"},{"code":"S01GX13","description":"Bilastine"}],"mesh":[],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"HRH1","mechanisms":["shared target"],"partners":3,"contraindicated":0}],"mechanism":"Bilastine is a selective histamine H1 receptor antagonist (Ki = 64nM). During allergic response mast cells undergo degranulation which releases histamine and other subastances. By binding to and preventing activation of the H1 receptor, bilastine reduces the development of allergic symptoms due to the release of histamine from mast cells.","side_effects":null,"effects":null,"usernotes":[{"user":"0xea","user_slug":"0xea","external":false,"note":{"substance":"Bilastine","composite":false,"routes":[{"name":"Oral","dosage":"20mg","onset":null,"comeup":null,"duration":null,"active":null}],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":["seamed too improve allergy symptoms"]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Australia","status":"S4 / Schedule 3; Schedule 2; Appendix H, clause 1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Prescription only","act":null,"refs":[4]},{"jurisdiction":"New Zealand","status":"S2 (Pharmacy Only)","act":null,"refs":[5]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Bilastine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/185460"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB11591"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1742423"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A135954"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=202189-78-4"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0240232"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D09570"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID5057678"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Bilastine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/PA1123N395"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 185460, Bilastine. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/185460>https://pubchem.ncbi.nlm.nih.gov/compound/185460</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bilastine. UNII: PA1123N395. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PA1123N395>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PA1123N395</a>","Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025. Therapeutic Goods Administration (TGA). May 2025. <a href='https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf'>https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf</a>","Health Canada New Drug Authorizations: 2016 Highlights. Health Canada. 14 March 2017. <a href='https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-canada-new-drug-authorizations-2016-highlights.html'>https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-canada-new-drug-authorizations-2016-highlights.html</a>","bilastine classification. (mcc). <a href='https://medsafe.govt.nz/profs/class/classintro.asp'>https://medsafe.govt.nz/profs/class/classintro.asp</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 13:51:31","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 13:51:27","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 13:51:27","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 13:51:27","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 13:51:27","note":"hmdb.ca refused automated access to HMDB0240232"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 13:51:28","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 13:51:27","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 13:51:27","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 13:51:27","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 13:51:27","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 13:51:27","note":null}],"description":"Bilastine is a  substance."}